Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
Conditions: Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate CancerInterventions: Radiation: radiation therapy; Other: laboratory biomarker analysisSponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; National Cancer Institute (NCI)Recruiting - verified September 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hormone Resistant Prostate Cancer | Hormones | Prostate Cancer | Radiation Therapy | Research